Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
BBP
65
HOLDINGS
18%
ALSO IN CANC
CANC
49
HOLDINGS
22%
ALSO IN BBP
SECTOR DRIFT (BBP minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 3.2% | 4.6% | 3.2% |
|
BEIGENE LTD. SPONSORED ADR | 2.9% | 2.9% | 2.9% |
|
GILEAD SCIENCES INC | 2.1% | 1.9% | 1.9% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 1.9% | 2.7% | 1.9% |
|
EXELIXIS INC | 1.8% | 3.0% | 1.8% |
BBP Overweight Relative to CANC
|
INSMED INC | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.0% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.0% |
|
MIRUM PHARMACEUTICALS, INC. | 3.0% |
|
IONIS PHARMACEUTICALS, INC. | 2.7% |
|
INTRA-CELLULAR THERAPIES INC | 2.6% |
|
ASCENDIS PHARMA A/S | 2.6% |
|
HALOZYME THERAPEUTICS INC | 2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | 2.5% |
|
SAGE THERAPEUTICS INC | 2.5% |
BBP Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.8% |
|
ELI LILLY & CO | -5.0% |
 |
GENMAB A/S SPONSORED ADR | -4.6% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
|
NOVARTIS AG | -4.4% |
 |
ASTRAZENECA PLC | -4.2% |
 |
MERUS N.V. | -4.0% |
|
ARCELLX, INC. | -3.7% |
|
NUVALENT, INC. CLASS A | -3.5% |
|
ABBVIE INC | -2.9% |